George Soros’s Achieve Life Sciences ACHV Stock Holding History

George Soros’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-14	Closed	-$115K	–	266
2014 Q2	$115K	Buy	+14	New	+$172K	﹤0.01%	317

Other funds holding ACHV

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.76% 1-Year Est. Return

George Soros's ACHV Position: Q3 2014 in Review

George Soros sold out of Achieve Life Sciences (ACHV) in Q3 2014, closing a stake of 14 shares — an estimated $115K sold.

George Soros first reported a position in ACHV in Q2 2014 and held it in 1 quarter. The position peaked at $115K in Q2 2014. 52 funds tracked by Wall St. Rank hold ACHV as of Q3 2014.

George Soros reported no remaining Achieve Life Sciences position as of Q3 2014 after selling out during the quarter.
George Soros sold 14 Achieve Life Sciences shares in Q3 2014, an estimated $115K.
George Soros first reported a position in Achieve Life Sciences in Q2 2014 and held it in 1 quarter.
George Soros's Achieve Life Sciences position peaked at $115K in Q2 2014.
52 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2014.

Based on Soros Fund Management's 13F filing for Q3 2014, filed 14 Nov 2014.